Pharmacophore modeling for hERG channel facilitation

Yuko Yamakawa, Kazuharu Furutani, Atsushi Inanobe, Yuko Ohno, Yoshihisa Kurachi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Human ether-a-go-go-related gene (hERG) channels play a critical role in cardiac action potential repolarization. The unintended block of hERG channels by compounds can prolong the cardiac action potential duration and induce arrhythmia. Several compounds not only block hERG channels but also enhance channel activation after the application of a depolarizing voltage step. This is referred to as facilitation. In this study, we tried to extract the property of compounds that induce hERG channel facilitation. We first examined the facilitation effects of structurally diverse hERG channel blockers in Xenopus oocytes. Ten of 13 assayed compounds allowed facilitation, suggesting that it is an effect common to most hERG channel blockers. We constructed a pharmacophore model for hERG channel facilitation. The model consisted of one positively ionizable feature and three hydrophobic features. Verification experiments suggest that the model well describes the structure-activity relationship for facilitation. Comparison of the pharmacophore for facilitation with that for hERG channel block showed that the spatial arrangement of features is clearly different. It is therefore conceivable that two different interactions of a compound with hERG channels exert two pharmacological effects, block and facilitation.

Original languageEnglish (US)
Pages (from-to)161-166
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume418
Issue number1
DOIs
StatePublished - Feb 3 2012
Externally publishedYes

Fingerprint

Ether
Genes
Action Potentials
Structure-Activity Relationship
Xenopus
Oocytes
Cardiac Arrhythmias
Chemical activation
Pharmacology
Electric potential

Keywords

  • Facilitation
  • HERG channel
  • Pharmacology
  • Pharmacophore model

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Pharmacophore modeling for hERG channel facilitation. / Yamakawa, Yuko; Furutani, Kazuharu; Inanobe, Atsushi; Ohno, Yuko; Kurachi, Yoshihisa.

In: Biochemical and Biophysical Research Communications, Vol. 418, No. 1, 03.02.2012, p. 161-166.

Research output: Contribution to journalArticle

Yamakawa, Y, Furutani, K, Inanobe, A, Ohno, Y & Kurachi, Y 2012, 'Pharmacophore modeling for hERG channel facilitation', Biochemical and Biophysical Research Communications, vol. 418, no. 1, pp. 161-166. https://doi.org/10.1016/j.bbrc.2011.12.153
Yamakawa, Yuko ; Furutani, Kazuharu ; Inanobe, Atsushi ; Ohno, Yuko ; Kurachi, Yoshihisa. / Pharmacophore modeling for hERG channel facilitation. In: Biochemical and Biophysical Research Communications. 2012 ; Vol. 418, No. 1. pp. 161-166.
@article{89c55ad9cb054c638c6597ff7614d818,
title = "Pharmacophore modeling for hERG channel facilitation",
abstract = "Human ether-a-go-go-related gene (hERG) channels play a critical role in cardiac action potential repolarization. The unintended block of hERG channels by compounds can prolong the cardiac action potential duration and induce arrhythmia. Several compounds not only block hERG channels but also enhance channel activation after the application of a depolarizing voltage step. This is referred to as facilitation. In this study, we tried to extract the property of compounds that induce hERG channel facilitation. We first examined the facilitation effects of structurally diverse hERG channel blockers in Xenopus oocytes. Ten of 13 assayed compounds allowed facilitation, suggesting that it is an effect common to most hERG channel blockers. We constructed a pharmacophore model for hERG channel facilitation. The model consisted of one positively ionizable feature and three hydrophobic features. Verification experiments suggest that the model well describes the structure-activity relationship for facilitation. Comparison of the pharmacophore for facilitation with that for hERG channel block showed that the spatial arrangement of features is clearly different. It is therefore conceivable that two different interactions of a compound with hERG channels exert two pharmacological effects, block and facilitation.",
keywords = "Facilitation, HERG channel, Pharmacology, Pharmacophore model",
author = "Yuko Yamakawa and Kazuharu Furutani and Atsushi Inanobe and Yuko Ohno and Yoshihisa Kurachi",
year = "2012",
month = "2",
day = "3",
doi = "10.1016/j.bbrc.2011.12.153",
language = "English (US)",
volume = "418",
pages = "161--166",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Pharmacophore modeling for hERG channel facilitation

AU - Yamakawa, Yuko

AU - Furutani, Kazuharu

AU - Inanobe, Atsushi

AU - Ohno, Yuko

AU - Kurachi, Yoshihisa

PY - 2012/2/3

Y1 - 2012/2/3

N2 - Human ether-a-go-go-related gene (hERG) channels play a critical role in cardiac action potential repolarization. The unintended block of hERG channels by compounds can prolong the cardiac action potential duration and induce arrhythmia. Several compounds not only block hERG channels but also enhance channel activation after the application of a depolarizing voltage step. This is referred to as facilitation. In this study, we tried to extract the property of compounds that induce hERG channel facilitation. We first examined the facilitation effects of structurally diverse hERG channel blockers in Xenopus oocytes. Ten of 13 assayed compounds allowed facilitation, suggesting that it is an effect common to most hERG channel blockers. We constructed a pharmacophore model for hERG channel facilitation. The model consisted of one positively ionizable feature and three hydrophobic features. Verification experiments suggest that the model well describes the structure-activity relationship for facilitation. Comparison of the pharmacophore for facilitation with that for hERG channel block showed that the spatial arrangement of features is clearly different. It is therefore conceivable that two different interactions of a compound with hERG channels exert two pharmacological effects, block and facilitation.

AB - Human ether-a-go-go-related gene (hERG) channels play a critical role in cardiac action potential repolarization. The unintended block of hERG channels by compounds can prolong the cardiac action potential duration and induce arrhythmia. Several compounds not only block hERG channels but also enhance channel activation after the application of a depolarizing voltage step. This is referred to as facilitation. In this study, we tried to extract the property of compounds that induce hERG channel facilitation. We first examined the facilitation effects of structurally diverse hERG channel blockers in Xenopus oocytes. Ten of 13 assayed compounds allowed facilitation, suggesting that it is an effect common to most hERG channel blockers. We constructed a pharmacophore model for hERG channel facilitation. The model consisted of one positively ionizable feature and three hydrophobic features. Verification experiments suggest that the model well describes the structure-activity relationship for facilitation. Comparison of the pharmacophore for facilitation with that for hERG channel block showed that the spatial arrangement of features is clearly different. It is therefore conceivable that two different interactions of a compound with hERG channels exert two pharmacological effects, block and facilitation.

KW - Facilitation

KW - HERG channel

KW - Pharmacology

KW - Pharmacophore model

UR - http://www.scopus.com/inward/record.url?scp=84856484667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856484667&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2011.12.153

DO - 10.1016/j.bbrc.2011.12.153

M3 - Article

C2 - 22244872

AN - SCOPUS:84856484667

VL - 418

SP - 161

EP - 166

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -